Federal Register / Vol. 75, No. 5 / Friday, January 8, 2010 / Notices 1063 

opportunity announcements; (2) conduct of 

Secondary Peer Review of extramural 

research grants, cooperative agreements, and 

contracts applications received in response to 

the funding opportunity announcements as it 

relates to the Center’s programmatic balance 

and mission; (3) submission of secondary 

review recommendations to the Center 

Director of applications to be considered for 

funding support; (4) review of research 

portfolios; and (5) review of program 

proposals. The board shall provide guidance 

on the National Center of Injury Prevention 

and Control’s programs and research 

activities by conducting scientific peer 

review of intramural research and programs 

within the National Center for Injury 

Prevention and Control; by ensuring 

adherence to Office of Management and 

Budget requirements for intramural peer 

review; and by monitoring the overall 

direction, focus, and success of the National 

Center for Injury Prevention and Control. 

Matters to be Discussed: As this meeting of 

the Board of Scientific Counselors, the board 

will be discussing the upcoming portfolio 

topics, activities promoting the Injury 

Research Agenda, and other scientific 

matters. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: Dr. 

Gwendolyn Cattledge, PhD, MSEH, Deputy 

Associate Director for Science and the 

Designated Federal Officer for the Board of 

Scientific Counselors, NCIPC, CDC, 4770 

Buford Highway, NE., Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (770) 

488–1430. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Gary J. Johnson, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2010–22 Filed 1–7–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Clinical Laboratory Improvement 

Advisory Committee (CLIAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following committee 

meeting: 

Times and Dates: 

8:30 a.m.–5 p.m., February 9, 2010. 

8:30 a.m.–3 p.m., February 10, 2010. 

Place: CDC, 1600 Clifton Road, NE., 

Tom Harkin Global Communications 

Center, Building 19, Room 232, 

Auditorium B, Atlanta, Georgia 30333. 

Online Registration Required: In order 

to expedite the security clearance 

process at the CDC Roybal Campus 

located on Clifton Road, all CLIAC 

attendees are required to register for the 

meeting online at least 14 days in 

advance at http://wwwn.cdc.gov/cliac/ 

default.aspx by clicking the ‘‘Register for 

a Meeting’’ link and completing all 

forms according to the instructions 

given. Please complete all the required 

fields before submitting your 

registration and submit no later than 

January 26, 2010. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 100 

people. 

Purpose: This Committee is charged 

with providing scientific and technical 

advice and guidance to the Secretary of 

Health and Human Services, the 

Assistant Secretary for Health, and the 

Director, CDC, regarding the need for, 

and the nature of, revisions to the 

standards under which clinical 

laboratories are regulated; the impact on 

medical and laboratory practice of 

proposed revisions to the standards; and 

the modification of the standards to 

accommodate technological advances. 

Matters To Be Discussed: The agenda 

will include updates from the CDC, the 

Centers for Medicare & Medicaid 

Services, and the Food and Drug 

Administration; a report from the CLIAC 

Biochemical Genetic Testing Workgroup 

and discussion of the Workgroup’s 

proposals related to good laboratory 

practices for biochemical genetic 

testing; and presentations and 

discussions related to electronic health 

records and electronic transmission of 

laboratory information. 

Agenda items are subject to change as 

priorities dictate. 

Providing Oral or Written Comments: 

It is the policy of CLIAC to accept 

written public comments and provide a 

brief period for oral public comments 

whenever possible. 

Oral Comments: In general, each 

individual or group requesting to make 

an oral presentation will be limited to 

a total time of five minutes (unless 

otherwise indicated). Speakers must 

also submit their comments in writing 

for inclusion in the meeting’s Summary 

Report. To assure adequate time is 

scheduled for public comments, 

individuals or groups planning to make 

an oral presentation should, when 

possible, notify the contact person 

below at least one week prior to the 

meeting date. 

Written Comments: For individuals or 

groups unable to attend the meeting, 

CLIAC accepts written comments until 

the date of the meeting (unless 

otherwise stated). However, the 

comments should be received at least 

one week prior to the meeting date so 

that the comments may be made 

available to the Committee for their 

consideration and public distribution. 

Written comments, one hard copy with 

original signature, should be provided 

to the contact person below. Written 

comments will be included in the 

meeting’s Summary Report. 

Contact Person for Additional 

Information: Nancy Anderson, Chief, 

Laboratory Practice Standards Branch, 

Division of Laboratory Systems, 

National Center for Preparedness, 

Detection, and Control of Infectious 

Diseases, CDC, 1600 Clifton Road, NE., 

Mailstop F–11, Atlanta, Georgia 30333; 

telephone (404) 498–2741; fax (404) 

498–2219; or via e-mail at 

Nancy.Anderson@cdc.hhs.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for CDC and the 

Agency for Toxic Substances and 

Disease Registry. 

Dated: December 30, 2009. 

Gary J. Johnson, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2010–100 Filed 1–7–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 


pwalker on DSK8KYBLC1PROD with NOTICES